It could be used for medications that help treat diabetes, high blood pressure, and chronic pain, among other conditions
These studies cannot be compared directly head to head, due to differences in study design and timepoints at which weight was measured
A published real-world study (Advances in Therapy, 2025) documented mean weight loss of 14.1% for semaglutide and 16.5% for tirzepatide over one year in nearly 10,000 patients on FDA-approved formulations - these research figures are not specific to compounded programs or to WellMedr
Published 2022 Nov 23
Originally isolated from human gastric juice, this 15-amino acid compound has been studied in preclinical animal models across multiple physiological systems.*1,9,10
The experience varies enormously